Senior insider sale
CONMED CORP — senior position signals high conviction
$107.0K
2K shares
What this filing means
FARKAS CHARLES plans to sell 2K shares of CONMED CORP valued at approximately $107.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2025ACC: 0001959173-25-005964
2K
Shares to sell
$107.0K
Approx. market value
2K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
SAR
Compensation
9/6/2024
466.00Restricted Stock Vesting
Compensation
5/31/2024
302.00Restricted Stock Vesting
Compensation
6/1/2023
335.00Restricted Stock Vesting
Compensation
6/1/2020
897.00Total acquired2K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/6/2024 | SAR Compensation | 466.00 | — |
5/31/2024 | Restricted Stock Vesting Compensation | 302.00 | — |
6/1/2023 | Restricted Stock Vesting Compensation | 335.00 | — |
6/1/2020 | Restricted Stock Vesting Compensation | 897.00 | — |
| Total | 2K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
2K
Market value
$107.0K
9/12/2025
Total
Units
2K
Value
$107.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/12/2025 | 2K | $107.0K | NYSE | Planned |
| Total | 2K | $107.0K | ||